Cargando…
Facilitating EMA binding test performance using fluorescent beads combined with next‐generation sequencing
The eosin‐5′‐maleimide (EMA) binding test is widely used as diagnostic test for hereditary spherocytosis (HS), one of the most common haemolytic disorders in Caucasian populations. We recently described the advantages of replacing the use of healthy control blood samples with fluorescent beads in a...
Autores principales: | Glenthøj, Andreas, Brieghel, Christian, Nardo‐Marino, Amina, van Wijk, Richard, Birgens, Henrik, Petersen, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176113/ https://www.ncbi.nlm.nih.gov/pubmed/35845192 http://dx.doi.org/10.1002/jha2.277 |
Ejemplares similares
-
Improving the EMA Binding Test by Using Commercially Available Fluorescent Beads
por: Glenthøj, Andreas, et al.
Publicado: (2020) -
Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
por: Madany, Emaan, et al.
Publicado: (2021) -
Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021) -
Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries
por: Jahangirpour, Mohammadali, et al.
Publicado: (2022) -
Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
por: Recht, Michael, et al.
Publicado: (2022)